Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants

International Journal of Cancer

Volumn 91, Issue 3, 2001, Pages 273-282

  Stratmann, Astrid ^a   Acker, Till ^b   Burger, Angelika M ^a   Amann, Kerstin ^c   Risau, Werner ^a   Plate, Karl H ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

TIE; Tumor angiogenesis; Tyrosine kinase receptors; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; MUTANT PROTEIN; RECEPTOR SUBTYPE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ADENOCARCINOMA, MUCINOUS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 0035255001     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q     Document Type: Article

References (51)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. What is the evidence that tumors are angiogenesis dependent?
3. Angiogenesis
4. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
5. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
7. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer
8. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
9. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
10. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
11. Microvessel quantitation and prognosis in invasive breast carcinoma
12. Mechanisms of angiogenesis
13. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
14. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
15. Role of the Flt-1 receptor tyrosine kinase in regulating assembly of vascular endothelium
16. Molecular mechanisms of developmental and tumor angiogenesis
17. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
18. Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant
19. Dominant-negative inhibition of flk-1 suppresses the growth of many tumor types in vivo
20. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy
21. Halting angiogenesis suppresses carcinoma cell invasion
22. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
23. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
24. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family
25. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial lineage
26. The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells
27. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
28. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
29. Isolation of angiopoietin-1, a ligand for the tie2 receptor, by secretion-trap expression cloning
30. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis
31. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis
32. Signaling vascular morphogenesis and maintenance
33. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
34. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
35. Cell-type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
36. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
37. Breast cancer
38. A safe packaging line for gene transfer: Separating viral genes on two different plasmids
39. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
40. High affinity VEGF binding and developmental expression suggests flk-1 as a major regulator of vasculogenesis and angiogenesis
41. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
42. Angiopoietin-1 induces sprouting angiogenesis in vitro
43. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
44. Increased vascularization in mice overexpressing angiopoietin-1
45. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
46. Up-regulation of flk-1/ vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
47. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
48. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
49. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
50. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2
51. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway